Mayo Clinic Laboratory and Pathology Research Roundup: March 11 - Insights
This week’s Research Roundup highlights an assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patients and several other research articles by Mayo Clinic physicians...
COVID-19: The pandemic that's forever changed laboratory testing - Insights
Since March 2020, the COVID-19 pandemic has had a lasting impact on the lives of millions of people around the world, including the many brave health care workers who risked their own health to provide lifesaving care to those infected by...
TPMT Testing in Treatment of Inflammatory Bowel Disease [Test in Focus] - Insights
Detection of individuals with low thiopurine methyltransferase (TPMT) activity who are at risk for excessive myelosuppression or severe hematopoietic toxicity when taking thiopurine drugs.
Thank you to all our staff during the time of COVID-19 - Insights
Thank you to our staff at Mayo Clinic who step up daily during this time of need to provide access to testing during the global pandemic. We appreciate each one of you and all the sacrifices you personally have made throughout this past...
Regaining quality of life after a decade lost to misdiagnosis: Kelly Dubois - Insights
Misdiagnosed with acromegaly, a disease marked by too much growth hormone, and plagued by a host of mysterious health problems from unnecessary medications, Kelly DuBois finally found answers after pharmacogenomic testing from Mayo Clinic...
Updated authentication for MayoACCESS client test environment - Insights
Mayo Clinic Laboratories will be migrating the MayoACCESS application to the authentication service used across Mayo Clinic.
New Strategies to Combat COVID-19: Dr. Bill Morice - Insights
This week on "Answers From the Lab,” William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his...
Study Shows Drug Reduces Risk of Relapse with Neuromyelitis Optica - Insights
"This study offers hope to patients, since each attack in NMO can cause loss of visual or motor function," says Sean Pittock, M.D., a Mayo Clinic neurologist and first author.
Dr. William Morice provides insights on the evolving technologies in medicine - Insights
In a Fierce Healthcare article, Dr. William Morice highlights AI, digital pathology, and mass spectrometry as key advancements revolutionizing healthcare diagnostics and treatment.
Dr. Morice predicts top impacts on the diagnostic industry in 2024 - Insights
William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, is a contributing author on Nasdaq.com. In his first article, Dr. Morice reflects on the diagnostic landscape and predicts trends that could...